WHO ICTRP trial
Effect of Saraswata ghrita on Alzheimers disease
CTRI/2020/03/024381 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/03/024381 |
|---|---|
| Public title | Effect of Saraswata ghrita on Alzheimers disease |
| Scientific title | Pharmaceutical Standardization of Saraswata Ghrita and its effect on Alzheimerâ??s Disease (Smritibhramsa) by Oral and Nasal Routes (A Randomized Controlled Clinical Trial) |
| Primary sponsor | All India Institute of Ayurveda |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: G309- Alzheimers disease, unspecified |
| Interventions | Intervention1: saraswata ghrita nasya: Patients will be treated with Nasya (2 Bindu each nostril) of Saraswata Ghrita twice a day along with conventional medicine for 90 days duration Intervention2: saraswata ghrita pana: Patients will be… |
| Registration date | Mar 31, 2020 |
| Target size | 45 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: